日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Society

China advised to create drug brands

By WANG XIAOYU | China Daily | Updated: 2018-08-27 08:34
Share
Share - WeChat
[Photo/VCG]

China should invest more in researching and developing new drugs, as well as intellectual property protection, even though generic versions of existing brand-name drugs can bring short-term benefits, said Margaret Chan, former director-general of the World Health Organization.

"Inexpensive generic drugs from India may play an important role in helping patients in poorer countries and regions, but China should not completely copy India's model because the country is capable of creating innovative new drugs, original ones," she said.

Chan made the remark on Thursday after watching the Chinese box-office hit Dying to Survive, a film about a man smuggling cheap versions of leukemia medications from India for resale to patients in China.

The film triggered a written instruction from the central government highlighting the urgency of reducing drug prices and ensuring adequate supplies as public discussion heated up after its release.

"In the long term, it's better for the country to create its own brand-name drugs," Chan said.

She called on the government to roll out more regulations to protect the intellectual property of research-based drug manufacturers to foster innovation.

"Based on my work experience at the WHO, we must protect intellectual property as an incentive to encourage research into original, better drugs," she said.

In China, the success rate of cancer drug development is less than 2 percent, and the average R&D cost is over $700 million, according to figures provided in April by the National Health Commission.

Chan said patent protection could be a driver for price increases, but better health insurance policies and more awareness of corporate social responsibility can help ease the pressure on those who cannot afford medicine.

At the State Council's executive meeting on Wednesday, the expansion of direct settlements for transprovincial medical expenses was approved. The new measure primarily benefits migrant workers and entrepreneurs.

"I'm glad to see the establishment of good policies like these. The next step is to ensure stronger enforcement," Chan said.

In addition, she said, she was "shocked and distressed" by the recent vaccine scandal involving Changchun Changsheng, a major vaccine producer in northeastern China that made and sold about 250,000 faulty doses.

"A well-designed supervision system does not necessarily guarantee safe production," she said. "The key is for drug companies to report their flaws to the public and regulators immediately, and for the government to take action and start investigating at once."

Chan, who stepped down from the WHO in June after 10 years in office, is now president of the first global health meeting of the Boao Forum for Asia, which will be held on Jan 10 and 11 in China.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 久久国产精品一区二区三区 | 日本精品久久久久中文字幕2 | 99久久精品费精品国产一区二区 | 久久久久久久免费看 | 麻豆md国产在线观看 | 一区二区视频在线 | 日韩在线观看中文字幕 | 国产精品中文在线 | 国产精品成人va在线观看入口 | 亚州av在线| 爱性久久久久久久 | 毛片免费在线观看 | 97色伦网 | 日本91| www.日韩在线 | 天天综合色天天桴色 | 成年人在线看片 | 久久精品成人免费国产片桃视频 | 国产一区二区三区久久 | 午夜伦4480yy私人影院 | 欧美一区二区三区爽大粗免费 | 久久精品国产免费 | 国产日韩一区在线精品欧美玲 | 国产精品久久久久一区二区 | 高清乱码一卡二卡插曲A | 添人人躁日日躁夜夜躁夜夜揉 | 日本呦呦| 99re视频在线观看 | 久久天天拍天天爱天天躁 | 色站网 | 999jjj在线播放 | 国内精品一区二区三区最新 | 国产精品天天天天影视 | 精品视频一区二区三区在线播放 | 思瑞在线观看 | 伊人狠狠 | 日韩在线免费 | 亚洲字幕在线观看 | 91小视频在线观看免费版高清 | 亚洲网站免费 | 超碰在线观看97 |